Published in Biochemistry on May 28, 1996
Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res (2009) 7.83
Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proc Natl Acad Sci U S A (1998) 1.58
Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions. J Biol Chem (2002) 1.36
Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res (2011) 1.35
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Inflammopharmacology (2011) 1.24
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic. Prog Mol Biol Transl Sci (2010) 1.14
Monomeric solution structure of the prototypical 'C' chemokine lymphotactin. Biochemistry (2001) 1.11
CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations. J Biol Chem (2008) 1.02
Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci U S A (2001) 1.01
The structural role of receptor tyrosine sulfation in chemokine recognition. Br J Pharmacol (2014) 0.98
Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus. J Virol (2012) 0.98
Cloning and characterization of deer mouse (Peromyscus maniculatus) cytokine and chemokine cDNAs. BMC Immunol (2004) 0.95
Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol (1999) 0.95
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol Cell Biol (2015) 0.94
Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family. Proteins (2010) 0.92
Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1). J Biol Chem (2012) 0.92
Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1). J Biol Chem (2013) 0.92
NMR analysis of the structure, dynamics, and unique oligomerization properties of the chemokine CCL27. J Biol Chem (2010) 0.92
Backbone dynamics of the human CC-chemokine eotaxin. J Biomol NMR (1999) 0.91
Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci U S A (2003) 0.89
The solution structure of the anti-HIV chemokine vMIP-II. Protein Sci (1999) 0.88
Effects of temperature and salt concentration on the structural stability of human lymphotactin: insights from molecular simulations. J Am Chem Soc (2006) 0.88
Breaking symmetry in the structure determination of (large) symmetric protein dimers. J Biomol NMR (2002) 0.87
Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2. Nat Commun (2015) 0.83
Chemokine oligomerization in cell signaling and migration. Prog Mol Biol Transl Sci (2013) 0.83
IFNβ autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages. FEBS Lett (2013) 0.80
Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Biochem J (2001) 0.79
The Structure of a CXCR4:Chemokine Complex. Front Immunol (2015) 0.78
Homology modeling and molecular dynamics simulations of lymphotactin. Protein Sci (2000) 0.75
Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™. Biomolecules (2013) 0.75
Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization. Open Biol (2017) 0.75
Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System. Pharmaceuticals (Basel) (2017) 0.75
Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry (1994) 3.72
Structure of the chromatin binding (chromo) domain from mouse modifier protein 1. EMBO J (1997) 1.90
Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature (1998) 1.61
Signal transduction in chemotaxis. A propagating conformation change upon phosphorylation of CheY. J Biol Chem (1994) 1.31
Assignments, secondary structure, global fold, and dynamics of chemotaxis Y protein using three- and four-dimensional heteronuclear (13C,15N) NMR spectroscopy. Biochemistry (1994) 1.29
The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat Struct Biol (1997) 1.22
Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy. Protein Sci (1996) 1.16
Structure of the cyclin-dependent kinase inhibitor p19Ink4d. Nature (1997) 1.05
Secondary structure and signal assignments of human-immunodeficiency-virus-1 protease complexed to a novel, structure-based inhibitor. Eur J Biochem (1994) 0.89
Sequential assignment of the backbone nuclei (1H, 15N and 13C) of c-H-ras p21 (1-166).GDP using a novel 4D NMR strategy. J Biomol NMR (1992) 0.78
Backbone resonance assignment of human UBC4. J Biomol NMR (2000) 0.78
1H, 15N and 13C assignments of the catalytic domain of E6-associated protein (E6AP). J Biomol NMR (2001) 0.75